A search for blood biomarkers for autism

Peptoids

Sayed Zaman, Umar Yazdani, Yan Deng, Wenhao Li, Bharathi S. Gadad, Linda Hynan, David Karp, Nichole Roatch, Claire Schutte, C. Nathan Marti, Laura Hewitson, Dwight C. German

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction and communication, and restricted, repetitive patterns of behavior. In order to identify individuals with ASD and initiate interventions at the earliest possible age, biomarkers for the disorder are desirable. Research findings have identified widespread changes in the immune system in children with autism, at both systemic and cellular levels. In an attempt to find candidate antibody biomarkers for ASD, highly complex libraries of peptoids (oligo-N-substituted glycines) were screened for compounds that preferentially bind IgG from boys with ASD over typically developing (TD) boys. Unexpectedly, many peptoids were identified that preferentially bound IgG from TD boys. One of these peptoids was studied further and found to bind significantly higher levels (>2-fold) of the IgG1 subtype in serum from TD boys (n = 60) compared to ASD boys (n = 74), as well as compared to older adult males (n = 53). Together these data suggest that ASD boys have reduced levels (>50%) of an IgG1 antibody, which resembles the level found normally with advanced age. In this discovery study, the ASD1 peptoid was 66% accurate in predicting ASD.

Original languageEnglish (US)
Article number19164
JournalScientific Reports
Volume6
DOIs
StatePublished - Jan 14 2016

Fingerprint

Peptoids
Autistic Disorder
Biomarkers
Immunoglobulin G
N-substituted Glycines
Antibodies
Interpersonal Relations
Autism Spectrum Disorder
Immune System
Communication

ASJC Scopus subject areas

  • General

Cite this

A search for blood biomarkers for autism : Peptoids. / Zaman, Sayed; Yazdani, Umar; Deng, Yan; Li, Wenhao; Gadad, Bharathi S.; Hynan, Linda; Karp, David; Roatch, Nichole; Schutte, Claire; Nathan Marti, C.; Hewitson, Laura; German, Dwight C.

In: Scientific Reports, Vol. 6, 19164, 14.01.2016.

Research output: Contribution to journalArticle

Zaman, S, Yazdani, U, Deng, Y, Li, W, Gadad, BS, Hynan, L, Karp, D, Roatch, N, Schutte, C, Nathan Marti, C, Hewitson, L & German, DC 2016, 'A search for blood biomarkers for autism: Peptoids', Scientific Reports, vol. 6, 19164. https://doi.org/10.1038/srep19164
Zaman, Sayed ; Yazdani, Umar ; Deng, Yan ; Li, Wenhao ; Gadad, Bharathi S. ; Hynan, Linda ; Karp, David ; Roatch, Nichole ; Schutte, Claire ; Nathan Marti, C. ; Hewitson, Laura ; German, Dwight C. / A search for blood biomarkers for autism : Peptoids. In: Scientific Reports. 2016 ; Vol. 6.
@article{8381d6f2297141519f2e88f377b86eeb,
title = "A search for blood biomarkers for autism: Peptoids",
abstract = "Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction and communication, and restricted, repetitive patterns of behavior. In order to identify individuals with ASD and initiate interventions at the earliest possible age, biomarkers for the disorder are desirable. Research findings have identified widespread changes in the immune system in children with autism, at both systemic and cellular levels. In an attempt to find candidate antibody biomarkers for ASD, highly complex libraries of peptoids (oligo-N-substituted glycines) were screened for compounds that preferentially bind IgG from boys with ASD over typically developing (TD) boys. Unexpectedly, many peptoids were identified that preferentially bound IgG from TD boys. One of these peptoids was studied further and found to bind significantly higher levels (>2-fold) of the IgG1 subtype in serum from TD boys (n = 60) compared to ASD boys (n = 74), as well as compared to older adult males (n = 53). Together these data suggest that ASD boys have reduced levels (>50{\%}) of an IgG1 antibody, which resembles the level found normally with advanced age. In this discovery study, the ASD1 peptoid was 66{\%} accurate in predicting ASD.",
author = "Sayed Zaman and Umar Yazdani and Yan Deng and Wenhao Li and Gadad, {Bharathi S.} and Linda Hynan and David Karp and Nichole Roatch and Claire Schutte and {Nathan Marti}, C. and Laura Hewitson and German, {Dwight C.}",
year = "2016",
month = "1",
day = "14",
doi = "10.1038/srep19164",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A search for blood biomarkers for autism

T2 - Peptoids

AU - Zaman, Sayed

AU - Yazdani, Umar

AU - Deng, Yan

AU - Li, Wenhao

AU - Gadad, Bharathi S.

AU - Hynan, Linda

AU - Karp, David

AU - Roatch, Nichole

AU - Schutte, Claire

AU - Nathan Marti, C.

AU - Hewitson, Laura

AU - German, Dwight C.

PY - 2016/1/14

Y1 - 2016/1/14

N2 - Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction and communication, and restricted, repetitive patterns of behavior. In order to identify individuals with ASD and initiate interventions at the earliest possible age, biomarkers for the disorder are desirable. Research findings have identified widespread changes in the immune system in children with autism, at both systemic and cellular levels. In an attempt to find candidate antibody biomarkers for ASD, highly complex libraries of peptoids (oligo-N-substituted glycines) were screened for compounds that preferentially bind IgG from boys with ASD over typically developing (TD) boys. Unexpectedly, many peptoids were identified that preferentially bound IgG from TD boys. One of these peptoids was studied further and found to bind significantly higher levels (>2-fold) of the IgG1 subtype in serum from TD boys (n = 60) compared to ASD boys (n = 74), as well as compared to older adult males (n = 53). Together these data suggest that ASD boys have reduced levels (>50%) of an IgG1 antibody, which resembles the level found normally with advanced age. In this discovery study, the ASD1 peptoid was 66% accurate in predicting ASD.

AB - Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction and communication, and restricted, repetitive patterns of behavior. In order to identify individuals with ASD and initiate interventions at the earliest possible age, biomarkers for the disorder are desirable. Research findings have identified widespread changes in the immune system in children with autism, at both systemic and cellular levels. In an attempt to find candidate antibody biomarkers for ASD, highly complex libraries of peptoids (oligo-N-substituted glycines) were screened for compounds that preferentially bind IgG from boys with ASD over typically developing (TD) boys. Unexpectedly, many peptoids were identified that preferentially bound IgG from TD boys. One of these peptoids was studied further and found to bind significantly higher levels (>2-fold) of the IgG1 subtype in serum from TD boys (n = 60) compared to ASD boys (n = 74), as well as compared to older adult males (n = 53). Together these data suggest that ASD boys have reduced levels (>50%) of an IgG1 antibody, which resembles the level found normally with advanced age. In this discovery study, the ASD1 peptoid was 66% accurate in predicting ASD.

UR - http://www.scopus.com/inward/record.url?scp=84955129979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955129979&partnerID=8YFLogxK

U2 - 10.1038/srep19164

DO - 10.1038/srep19164

M3 - Article

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 19164

ER -